American Heart Month
This February, AdvaMed is working with member companies and our global partners to raise awareness and highlight the ways medical technology helps those living with cardiovascular disease live healthier, happier lives.
Medtech’s Role in Living a Heart Healthy Life
Each February, AdvaMed and our member companies work to raise awareness about heart health, emphasizing the importance of understanding, preventing, and managing cardiovascular disease. This disease, affecting millions of lives each year, is the leading cause of death in the United States. Through education, lifestyle changes, and advancements in medical technology, it is possible to reduce the impact of cardiovascular disease and live a heart-healthy life.
Join us in this month-long campaign to make a positive impact and promote healthy lifestyles for Americans living with cardiovascular disease.
Social Media Toolkit
Over the course of American Heart Month, AdvaMed and our partners encourage you to raise awareness about cardiovascular disease and the role of medtech in treating patients. Consider using the below graphics on your own social media channels or engaging with AdvaMed on X and LinkedIn.
Page / Workforce Inclusion & Diversity
Women in Cardiovascular Device Trials
AdvaMed members have launched a public awareness campaign to encourage recruitment, enrollment and retention of women in cardiovascular device trials.
Facts About Cardiovascular Disease
- Cardiovascular disease (CVD) remains the leading cause of death in the United States, accounting for 928,741 deaths in 2020.
- In 2020, the leading cause of deaths attributable to CVD in the United States was coronary heart disease (CHD) at 41.2%, followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%), and diseases of the arteries (2.6%).
- The direct and indirect costs of total CVD in the United States between 2018 and 2019 were $407.3 billion ($251.4 billion in direct costs and $155.9 billion in lost productivity/mortality).
- On average, someone dies of CVD every 36 seconds in the United States.
- Globally, CVDs are the leading cause of death, accounting for 32% of all global deaths in 2019.
The Future of Cardiovascular Disease Treatment
- Wearable devices that monitor heart rate, blood pressure, oxygen saturation, and other vital signs, and alert patients and doctors of any abnormalities or emergencies.
- Artificial intelligence that analyzes large amounts of data from electronic health records, imaging, and wearable devices, and provides insights for diagnosis, prognosis, and treatment of cardiovascular disease.
- Stem cell therapy that uses the patient’s own cells to regenerate damaged heart tissue and improve cardiac function.
- Nanotechnology that delivers drugs or genes to specific targets in the heart, such as plaque, inflammation, or ischemia, and enhances the efficacy and safety of therapies.
- 3D printing that creates personalized models of the heart, valves, vessels, and implants, and facilitates surgical planning, simulation, and training.
Learn more about the history of cardiovascular disease treatment here.
